ArticleBrain communications2026
Anatomical phenotyping and staging of brain arteriovenous malformations.
Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Cell Analysis of Brain Arteriovenous Malformations Reveals Pro-Angiogenic Myeloid Programs.Brain sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain arteriovenous malformations (AVMs) are potentially life-threatening vascular anomalies that pose significant clinical challenges due to their heterogeneous anatomy and unpredictable natural history. Existing risk stratification models largely rely on isolated imaging markers and fail to account for the dynamic spatial-temporal complexity of AVMs. Building on our prior work, demonstrating how ontogenesis dictates clinical outcomes of neuroepithelial tumours, we hypothesize that AVMs are similarly influenced by developmental processes that define their spatial distribution, vascular architecture and susceptibility to complications. Here, we present the protocol and pilot data of our multicentre, retrospective and prospective observational study, which introduces a multidimensional approach integrating precise anatomical phenotyping with ontogenetic mapping and the analysis of dynamic structural changes over time. By leveraging unsupervised non-negative matrix factorization, we identified six biologically plausible meta-topologies in our single-centre pilot dataset of 416 patients, supporting the feasibility of this approach. We now seek to expand the study into a multicentre effort with both retrospective and prospective enrollment, aiming for a total sample size of ∼1000 patients. This expansion is essential to enhance the granularity, reproducibility and clinical utility of the meta-topologies. Ultimately, the objective of this integrative framework is to facilitate the development of a robust biologically informed risk-stratifying staging system, enhancing personalized treatment strategies and optimizing patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.